OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Fasting glucose level reduction induced by imatinib in chronic myeloproliferative disease with TEL-PDGFRβ rearrangement and type 1 diabetes
Adriano Salaroli, Giuseppina Loglisci, Alessandra Serrao, et al.
Annals of Hematology (2012) Vol. 91, Iss. 11, pp. 1823-1824
Closed Access | Times Cited: 17
Adriano Salaroli, Giuseppina Loglisci, Alessandra Serrao, et al.
Annals of Hematology (2012) Vol. 91, Iss. 11, pp. 1823-1824
Closed Access | Times Cited: 17
Showing 17 citing articles:
Tyrosine Kinase Inhibitors and Diabetes: A Novel Treatment Paradigm?
Athanasios Fountas, Leonidas Nikolaos Diamantopoulos, Agathocles Tsatsoulis
Trends in Endocrinology and Metabolism (2015) Vol. 26, Iss. 11, pp. 643-656
Closed Access | Times Cited: 88
Athanasios Fountas, Leonidas Nikolaos Diamantopoulos, Agathocles Tsatsoulis
Trends in Endocrinology and Metabolism (2015) Vol. 26, Iss. 11, pp. 643-656
Closed Access | Times Cited: 88
A PPARγ transcriptional cascade directs adipose progenitor cell-niche interaction and niche expansion
Yuwei Jiang, Daniel C. Berry, A-Young Jo, et al.
Nature Communications (2017) Vol. 8, Iss. 1
Open Access | Times Cited: 45
Yuwei Jiang, Daniel C. Berry, A-Young Jo, et al.
Nature Communications (2017) Vol. 8, Iss. 1
Open Access | Times Cited: 45
New onset diabetes manifesting as diabetic ketoacidosis in a patient with chronic myelogenous leukemia treated with imatinib
Dinara Salimova, Tatevik Aloyan, Ursula Qureshi, et al.
Archives of Endocrinology and Metabolism (2025) Vol. 69, Iss. 2, pp. 1-4
Open Access
Dinara Salimova, Tatevik Aloyan, Ursula Qureshi, et al.
Archives of Endocrinology and Metabolism (2025) Vol. 69, Iss. 2, pp. 1-4
Open Access
Tyrosine kinase inhibitors of Ripk2 attenuate bacterial cell wall-mediated lipolysis, inflammation and dysglycemia
Brittany M. Duggan, Kevin P. Foley, Brandyn D. Henriksbo, et al.
Scientific Reports (2017) Vol. 7, Iss. 1
Open Access | Times Cited: 37
Brittany M. Duggan, Kevin P. Foley, Brandyn D. Henriksbo, et al.
Scientific Reports (2017) Vol. 7, Iss. 1
Open Access | Times Cited: 37
Expert opinion on the metabolic complications of new anticancer therapies: Tyrosine kinase inhibitors
P. Buffier, Benjamin Bouillet, Sarra Smati, et al.
Annales d Endocrinologie (2018) Vol. 79, Iss. 5, pp. 574-582
Closed Access | Times Cited: 26
P. Buffier, Benjamin Bouillet, Sarra Smati, et al.
Annales d Endocrinologie (2018) Vol. 79, Iss. 5, pp. 574-582
Closed Access | Times Cited: 26
RIPK2 Dictates Insulin Responses to Tyrosine Kinase Inhibitors in Obese Male Mice
Brittany M. Duggan, Joseph F. Cavallari, Kevin P. Foley, et al.
Endocrinology (2020) Vol. 161, Iss. 8
Open Access | Times Cited: 19
Brittany M. Duggan, Joseph F. Cavallari, Kevin P. Foley, et al.
Endocrinology (2020) Vol. 161, Iss. 8
Open Access | Times Cited: 19
Effect of imatinib on plasma glucose concentration in subjects with chronic myeloid leukemia and gastrointestinal stromal tumor
Miguel Ángel Gómez-Sámano, Jorge Baquerizo‐Burgos, Marı́a Florencia Coronel, et al.
BMC Endocrine Disorders (2018) Vol. 18, Iss. 1
Open Access | Times Cited: 20
Miguel Ángel Gómez-Sámano, Jorge Baquerizo‐Burgos, Marı́a Florencia Coronel, et al.
BMC Endocrine Disorders (2018) Vol. 18, Iss. 1
Open Access | Times Cited: 20
The pharmacokinetics and hypoglycaemic effect of sunitinib in the diabetic rabbits
Edyta Szałek, Agnieszka Karbownik, Katarzyna Sobańska, et al.
Pharmacological Reports (2014) Vol. 66, Iss. 5, pp. 892-896
Closed Access | Times Cited: 12
Edyta Szałek, Agnieszka Karbownik, Katarzyna Sobańska, et al.
Pharmacological Reports (2014) Vol. 66, Iss. 5, pp. 892-896
Closed Access | Times Cited: 12
The Role of Imatinib in Pediatric Type 1 Diabetes
Kristen Lavelle, Chester E. Chamberlain, Michael German, et al.
JCEM Case Reports (2024) Vol. 2, Iss. 5
Open Access | Times Cited: 1
Kristen Lavelle, Chester E. Chamberlain, Michael German, et al.
JCEM Case Reports (2024) Vol. 2, Iss. 5
Open Access | Times Cited: 1
Slow progression of type 1 diabetes associated with pembrolizumab and lenvatinib combination therapy in a patient with probable slowly progressive type 1 diabetes mellitus and endometrial cancer
Iwaho Hazekawa, Norio Ishii
Diabetology International (2024)
Closed Access | Times Cited: 1
Iwaho Hazekawa, Norio Ishii
Diabetology International (2024)
Closed Access | Times Cited: 1
Tyrosine Kinase Targeting
Mohammad Althubiti
Saudi Journal of Medicine and Medical Sciences (2022) Vol. 10, Iss. 3, pp. 183-191
Open Access | Times Cited: 7
Mohammad Althubiti
Saudi Journal of Medicine and Medical Sciences (2022) Vol. 10, Iss. 3, pp. 183-191
Open Access | Times Cited: 7
Kinase inhibitors for cancer alter metabolism, blood glucose, and insulin
Brittany M. Duggan, Daniel M. Marko, Raveen Muzaffar, et al.
Journal of Endocrinology (2022)
Open Access | Times Cited: 7
Brittany M. Duggan, Daniel M. Marko, Raveen Muzaffar, et al.
Journal of Endocrinology (2022)
Open Access | Times Cited: 7
Tyrosine kinase inhibitor imatinib modulates the viability and apoptosis of castrate-resistant prostate cancer cells dependently on the glycolytic environment
Henrique J. Cardoso, Cátia V. Vaz, Tiago M. A. Carvalho, et al.
Life Sciences (2018) Vol. 218, pp. 274-283
Closed Access | Times Cited: 11
Henrique J. Cardoso, Cátia V. Vaz, Tiago M. A. Carvalho, et al.
Life Sciences (2018) Vol. 218, pp. 274-283
Closed Access | Times Cited: 11
Fusion of platelet-derived growth factor receptor β to CEV14 gene in chronic myelomonocytic leukemia: A case report and review of the literature
Shenglan Gong, Mengqiao Guo, Gusheng Tang, et al.
Oncology Letters (2015) Vol. 11, Iss. 1, pp. 770-774
Open Access | Times Cited: 9
Shenglan Gong, Mengqiao Guo, Gusheng Tang, et al.
Oncology Letters (2015) Vol. 11, Iss. 1, pp. 770-774
Open Access | Times Cited: 9
Imatinib protects against human beta-cell death via inhibition of mitochondrial respiration and activation of AMPK
Andris Elksnis, Tomas A. Schiffer, Fredrik Palm, et al.
Clinical Science (2021) Vol. 135, Iss. 19, pp. 2243-2263
Open Access | Times Cited: 7
Andris Elksnis, Tomas A. Schiffer, Fredrik Palm, et al.
Clinical Science (2021) Vol. 135, Iss. 19, pp. 2243-2263
Open Access | Times Cited: 7
Cardiovascular Damage Induced by Anti-BCR-ABL TKIs
Giuseppina Novo, Daniela Di Lisi, Manuela Fiúza, et al.
Current clinical pathology (2018), pp. 45-55
Closed Access
Giuseppina Novo, Daniela Di Lisi, Manuela Fiúza, et al.
Current clinical pathology (2018), pp. 45-55
Closed Access
RIPK2 dictates insulin responses to tyrosine kinase inhibitors in obese mice
Brittany M. Duggan, Joseph F. Cavallari, Kevin P. Foley, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2020)
Open Access
Brittany M. Duggan, Joseph F. Cavallari, Kevin P. Foley, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2020)
Open Access
